Baxter International Inc

BAX

Equity

ISIN US0718131099 / Valor 911702

New York Stock Exchange, Inc (2024-11-19)

USD 32.52-1.51%

Baxter International Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Baxter International Inc is a global healthcare company that focuses on hospital, nutrition, renal, and surgical care. The company provides a range of products and services, including hemostatic agents, generic injectables, parenteral nutrition systems, and dialysis therapies. Baxter BioPharma Solutions, a contract manufacturing organization, has entered into agreements with leading companies to provide manufacturing services for COVID-19 vaccines and diagnostic tests. The company's recent acquisition of Hillrom has expanded its opportunities for innovation and access to care worldwide. Baxter is committed to transforming healthcare and advancing patient care from the hospital to the home, with a focus on improving outcomes for patients with chronic conditions such as end-stage renal disease.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-8.29%1Y

-59.0%3Y

-60.2%5Y

Performance

26.3%1Y

30.1%3Y

29.7%5Y

Volatility